(R)-1-(4,5-Dimethylthiazol-2-yl)ethanol

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: (R)-1-(4,5-Dimethylthiazol-2-yl)ethanol
• 英文别名: (1R)-1-(4,5-dimethyl-1,3-thiazol-2-yl)ethanol
• 化学式: C₇H₁₁NOS
• 分子量: 157.24
• InChiKey: GEEFPWNWTUMMKP-RXMQYKEDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  61.4
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Small molecule inhibitors of NF-κB inducing kinase
  申请人：Janssen Pharmaceutica NV

  公开号：US11254673B2

  公开（公告）日：2022-02-22

  The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.

  本发明涉及抑制 NIK 的化合物、含有此类化合物的药物组合物以及使用方法。根据设想，这些化合物和药物组合物可用于预防或治疗癌症（如 B 细胞恶性肿瘤，包括白血病、淋巴瘤和骨髓瘤）、炎症性疾病、自身免疫性疾病、免疫性皮肤病（如掌跖脓疱病和化脓性扁桃体炎）以及代谢性疾病（如肥胖症和糖尿病）等疾病。
• SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE
  申请人：Janssen Pharmaceutica NV

  公开号：US20210300918A1

  公开（公告）日：2021-09-30

  The present invention relates to compounds that inhibit NIK and pharmaceutical compositions comprising such compounds and methods of using the same. These compounds and pharmaceutical compositions are envisaged to be useful for preventing or treating diseases such as cancer (such as B-cell malignancies including leukemias, lymphomas and myeloma), inflammatory disorders, autoimmune disorders, immunodermatologic disorders such as palmoplantar pustulosis and hidradenitis suppurativa, and metabolic disorders such as obesity and diabetes.